Novel mechanism of resistance to targeted therapies in lung cancer

被引：3
|
作者：
Wang, Walter [1 ]
Carbone, David P. [1 ]
Arasada, Rajeswara Rao [1 ]
机构：
[1] Ohio State Univ, Med Ctr, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA
来源：
MOLECULAR & CELLULAR ONCOLOGY | 2019年 / 6卷 / 01期
关键词：
EGFR; Notch3; EGFR TKI; drug persister cells; cancer stem cells; PATHWAY; NOTCH;
D O I：
10.1080/23723556.2018.1551015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
We have identified a non-canonical role of0 Notch3 in response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) therapy, whereby Notch3 associates with beta-catenin, resulting in increased catenin beta-1 (CTNNB1, best known as beta-catenin) stability and increased survival of drug persister cells (DPCs). Furthermore, combined treatment of an EGFR TKI with a beta-catenin inhibitor demonstrated improved therapeutic outcomes in xenograft models.
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Overcoming Resistance to Targeted Therapies in Cancer
    Redmond, Keara L.
    Papafili, Anastasia
    Lawler, Mark
    Van Schaeybroeck, Sandra
    SEMINARS IN ONCOLOGY, 2015, 42 (06) : 896 - 908
  • [22] Targeted therapies in cancer and mechanisms of resistance
    Simona Corso
    Silvia Giordano
    Journal of Molecular Medicine, 2014, 92 : 677 - 679
  • [23] Adaptive resistance to targeted therapies in cancer
    Rosell, Rafael
    Karachaliou, Niki
    Morales-Espinosa, Daniela
    Costa, Carlota
    Molina, Miguel Angel
    Sansano, Irene
    Gasco, Amaya
    Viteri, Santiago
    Massuti, Bartomeu
    Wei, Jia
    Cao, Maria Gonzalez
    Bueno, Alejandro Martinez
    TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (03) : 152 - 159
  • [24] Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinoma
    Neel, Dana S.
    Bivona, Trever G.
    NPJ PRECISION ONCOLOGY, 2017, 1
  • [25] Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinoma
    Dana S. Neel
    Trever G. Bivona
    npj Precision Oncology, 1
  • [26] Novel Targeted Therapies for Prostate Cancer
    Macfarlane, Robyn J.
    Chi, Kim N.
    UROLOGIC CLINICS OF NORTH AMERICA, 2010, 37 (01) : 105 - +
  • [27] Novel Targeted Therapies for Esophagogastric Cancer
    Maron, Steven B.
    Catenacci, Daniel V. T.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 26 (02) : 293 - +
  • [28] Novel targeted therapies for cancer cachexia
    Argiles, Josep M.
    Javier Lopez-Soriano, Francisco
    Stemmler, Britta
    Busquets, Silvia
    BIOCHEMICAL JOURNAL, 2017, 474 : 2663 - 2678
  • [29] Novel therapies in lung cancer
    Hahn, O
    Salgia, R
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2005, 19 (02) : 343 - +
  • [30] Novel therapies for lung cancer
    Hoang, T
    Traynor, AM
    Schiller, JH
    SURGICAL ONCOLOGY-OXFORD, 2002, 11 (04): : 229 - 241
12345